Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T17:31:34.751Z.
Calculation as of: 2026-10-06T17:31:34.751Z.
Quote observation: 2026-10-06T16:43:20.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 015f4768d679608bc4b6bcfba81ca244afda57a14a617ca6285ea64adc9468bc
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Drugs Made In America Acquisition Corp. Ordinary Shares
Market Cap
$264.17M
Free Cash Flow Yield
N/A
Market Cap
$261.73M
Free Cash Flow Yield
N/A
Market Cap
$261.39M
Free Cash Flow Yield
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD |
|---|---|---|
| Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) | $264.17M | N/A |
| ProCap Acquisition Corp (PCAP)vs › | $264.47M | N/A |
| Oaktree Acquisition Corp. II (OACC)vs › | $264.76M | N/A |
| Soren Acquisition Corp. (SORN)vs › | $263.53M | N/A |
| Hawthorn Bancshares, Inc. (HWBK)vs › | $266.64M | N/A |
| Thunder Bridge Capital Partners V L (TBCVU)vs › | $266.05M | N/A |
| Translational Development Acquisition Corp. (TDAC)vs › | $266.50M | N/A |
| AMR Resources Acquisition Corp Class A Ordinary Shares (AMAC)vs › | $261.73M | N/A |
| Mountain Lake Acquisition Corp. II Class A Ordinary Shares (MLAA)vs › | $261.39M | N/A |
| Cantor Equity Partners V, Inc. Class A Ordinary Shares (CEPV)vs › | $261.27M | N/A |
FCF Yield
N/A
Earnings Yield
1.80%
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
